Healthcare Integrated Technologies, Inc.

Healthcare Integrated Technologies, Inc., through its subsidiary, develops healthcare technology solutions to integrate and automate the continuing care, home care, and professional healthcare spaces. The company's product includes SafeSpace, an ambient fall detection solution for continuing care communities and at home use. It provides healthcare services and health and safety monitoring equipment; and integrated solution for the professional healthcare community that integrates electronic health records, remote patient monitoring, telehealth, and other items. Healthcare Integrated Technologies, Inc. has a strategic partnership with Servant Rehab to deliver AI-driven, professional fall prevention and rehabilitation therapy for senior living. The company was formerly known as Grasshopper Staffing, Inc. and changed its name to Healthcare Integrated Technologies, Inc. in May 2018. Healthcare Integrated Technologies, Inc. was incorporated in 2013 and is based in Knoxville, Tennessee.

Healthcare Integrated Technologies, Inc. trades as HITC on OTC. The company is classified in Healthcare / Medical - Healthcare Information Services and reports in USD.

The current profile places the business in Medical - Healthcare Information Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $0 of revenue and -$4.64M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Healthcare Integrated Technologies, Inc. can be compared against peers such as Assisted 4 Living, Inc., Biostage, Inc., Herantis Pharma Oyj, INNOCAN PHARMA Corp, MCI Onehealth Technologies Inc., MedPeer,Inc..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $52.84M, beta of 0.59, and return on equity of -61.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

HITC currently shows total debt of $0 and beta of 0.59. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 8-K (2026-05-22 00:00:00), 8-K (2026-05-18 00:00:00), 8-K (2026-05-01 00:00:00), 8-K (2026-04-28 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.gethitc.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.